Acsys Interactive's recommendations to the FDA on social media in the healthcare industry

NewsGuard 100/100 Score

At the invitation of the Food and Drug Administration, Stan Valencis, President of Acsys Interactive, recently presented a series of recommendations to help shape the government's policy towards the promotion of prescription drugs, biologics and medical devices using the Internet and social media tools. As a leader in providing digital marketing and interactive strategies to healthcare systems, hospitals, device manufacturers and pharmaceutical companies, Acsys Interactive was selected by the FDA to provide its uniquely qualified perspective and experience.

"Social media is rapidly becoming an integral source of medical information to millions of consumers seeking to improve their overall health and find effective treatment options," states Stan Valencis. "We appreciate the FDA's invitation to present our recommendations and their collaborative approach in seeking the recommendations of leaders across the healthcare industry. While technology is changing quickly and as such, needs to be reacted to quickly, we must maintain a balanced approach that encourages innovation while also ensuring the protection of consumers from sources of misinformation accessible via the Internet."

The key messages from Stan Valencis' testimony at the FDA's public hearings conducted in Washington, DC on November 12th and 13th include:

-- Growing Importance of Social Media in Society

-- Adoption of Social Media Amongst Healthcare Marketing Organizations

-- Biggest Obstacles to Adoption Are Transparency, Liability and Best Practices

-- Establish Authenticity of Medical Content with Introduction of FDA Seal of Approval

Full Details: Acsys Interactive's FDA Recommendations

Read the Company's detailed press release or watch Stan Valencis speak to the FDA as the government agency evaluates special characteristics of Web 2.0 and other emerging technologies that may require the agency to provide additional guidance to the industry on how the regulations should be applied.

Source:

Acsys Interactive

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI technologies can accurately identify cases of healthcare-associated infections